Moderna plans to file for EUA of COVID-19 shot for very young kids by April end
Last week, Pfizer and BioNTech said a third dose of the COVID-19 vaccine produced significant protection against the Omicron…
Author
US FTC approves Hikma deal for Custopharm with conditions
Hikma, which makes anaesthetics, pain medications, sedatives, neuromuscular agents and other drugs, announced the deal in…
J&J suspends COVID-19 vaccine sales forecast
The vaccine brought in $2.38 billion in sales last year
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved…
Canada authorises AstraZeneca’s drug for COVID prevention
The therapy has already been authorised in the US and its use has also been recommended by the European Medicines Agency (EMA)
Nektar stops clinical trials for key cancer drug
The trials that Nektar stopped included those involving a combination of its drug Bempegaldesleukin with Bristol Myers Squibb Co’s…
Poorer nations shun millions of AstraZeneca COVID-19 vaccine doses
Countries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson…
Britain approves Valneva’s easy-to-store COVID shot
The shot is also the sixth COVID-19 vaccine to be approved in the UK
Britain widens access to Pfizer’s COVID anti-viral drug through trial
Paxlovid, a combination of Pfizer's new pill with an older anti-viral ritonavir, was made available to thousands of people with…
FDA lifts partial clinical hold on Gilead’s blood cancer drug trials
The health regulator had placed the hold on five cancer trials in January due to an imbalance in suspected and unexpected serious…